SPI.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:35):

Stats
Today's Volume	191 117
Average Volume	570 397
Market Cap	993.40M
EPS	£0 ( 2024-02-28 )
Last Dividend	£0.500 ( 2023-05-25 )
Next Dividend	£0 ( N/A )
P/E	35.14
ATR14	£0.335 (0.14%)

Volume Correlation

Long: -0.04 (neutral)

Short: -0.24 (neutral)

Signal:(54.2) Neutral

Spire Healthcare Group Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spire Healthcare Group Correlation - Currency/Commodity

-0.65
( weak negative )

-0.40
( neutral )

0.75
( moderate )

-0.47
( neutral )

0.70
( moderate )

-0.04
( neutral )

Spire Healthcare Group Financials

Annual	2023
Revenue:	£1.36B
Gross Profit:	£520.60M (38.31 %)
EPS:	£0.0676

Q4	2023
Revenue:	£682.50M
Gross Profit:	£256.50M (37.58 %)
EPS:	£0.0369

Q2	2023
Revenue:	£676.50M
Gross Profit:	£264.10M (39.04 %)
EPS:	£0.0307

Q4	2022
Revenue:	£600.60M
Gross Profit:	£222.20M (37.00 %)
EPS:	£0.0226

Financial Reports:

No articles found.

Spire Healthcare Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0.500 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Spire Healthcare Group Dividend Information - Dividend Junior

Dividend Sustainability Score: 8.39 - good (83.93%) | Divividend Growth Potential Score: 4.14 - Stable (17.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£1.800	2015-06-04
Last Dividend	£0.500	2023-05-25
Next Dividend	£0	N/A
Payout Date	2023-06-23
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	£21.20	--
Avg. Dividend % Per Year	0.18%	--
Score	2.57	--
Div. Sustainability Score	8.39
Div.Growth Potential Score	4.14
Div. Directional Score	6.26	--

Next Divdend (Est)
(2024-05-09)

£0.0693 Estimate 3.33 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.57

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£3.80	1.64%
2019	£3.80	3.44%
2020	£2.50	1.76%
2021	£0	0.00%
2022	£0	0.00%
2023	£0.500	0.22%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
KYGA.L	Dividend Knight	2023-10-12	Semi-Annually	25	0.55%
CHH.L	Dividend Knight	2023-09-21	Annually	30	1.09%
RBGP.L	Dividend Junior	2023-05-04	Semi-Annually	6	2.45%
GRI.L	Dividend Knight	2023-05-25	Semi-Annually	32	1.04%
ARTL.L	Dividend Knight	2023-09-28	Quarterly	12	1.39%
TPT.L	Dividend Knight	2023-06-08	Annually	27	2.93%
MERC.L	Ex Dividend Junior	2023-09-28	Annually	5	0.78%
CTO.L	Dividend King	2023-08-31	Semi-Annually	32	2.55%
RWS.L	Dividend Knight	2023-06-22	Semi-Annually	21	1.50%
HTG.L	Dividend Knight	2023-10-05	Semi-Annually	32	1.82%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0201	1.500	9.60	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0119	1.200	9.60	10.00	[0 - 0.3]
returnOnEquityTTM	0.0372	1.500	-0.698	-1.047	[0.1 - 1]
payoutRatioTTM	0.147	-1.000	8.53	-8.53	[0 - 1]
currentRatioTTM	0.691	0.800	-1.544	-1.236	[1 - 3]
quickRatioTTM	0.470	0.800	-1.941	-1.553	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.243	-0.365	[0.2 - 2]
debtRatioTTM	0.203	-1.500	6.62	-9.93	[0 - 0.6]
interestCoverageTTM	1.360	1.000	-0.607	-0.607	[3 - 30]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.286	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.627	-1.500	7.49	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.383	1.000	6.95	6.95	[0.2 - 0.8]
operatingProfitMarginTTM	0.0931	1.000	-0.138	-0.138	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.431	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	0.594	0.800	9.37	7.50	[0.5 - 2]
Total Score				8.39

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.03	1.000	6.56	0	[1 - 100]
returnOnEquityTTM	0.0372	2.50	-0.449	-1.047	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.286	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0.211	1.500	4.73	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.495	2.00	9.83	10.00	[0 - 30]
payoutRatioTTM	0.147	1.500	8.53	-8.53	[0 - 1]
pegRatioTTM	-36.73	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.147	1.000	8.82	0	[0.1 - 0.5]
Total Score				4.14

Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.